Delivery Order SPE2DB22D3301-SPE2DB24FY4VR
- Not listed
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The Delivery Order has a ceiling value of $31,404.78 and provides for the supply of Ondansetron ODT 4 mg Tablets. The contract does...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, demonstrates the company's role in supplying critical medical products to the U.S. government. The $5,822.41 delivery order, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the procurement of 4,566,361,768 units of the generic drug Ondansetron ODT 8 mg tablets. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides the Defense Logistics Agency (DLA) with a range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The $10,302.24 Firm Fixed Price Delivery Order contract covers the supply of Ondansetron HCL 4 mg tablets, with a completion date of July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The award, which is not set aside, is for the delivery of Ondansetron ODT 8 mg Tablets in quantities of 30s, with a ceiling value of $1,436.40 and a completion date of July 17, 2025. As a prime contractor,...
- This federal contract award was issued by the Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,915.86 Firm Fixed Price Delivery Order is for the supply of 4,564,803,723 units of Ondansetron ODT 4 mg tablets. This contract is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award is an order under an existing Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific order awarded is for 4,567,828,721 units of Ondansetron HCL 8 mg...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation (Amerisourcebergen), a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,346.63 firm fixed price delivery order is for the supply of Ondansetron ODT 8 mg tablets to support military treatment programs and facilities. This award is a task order under Amerisourcebergen's $999,999,999.00 indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $16,900.64, is a Firm Fixed Price Delivery Order with a completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 4 mg tablets. The $7,500.96 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as a comprehensive contracting vehicle for the company to supply a wide range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,350.07 firm fixed price delivery order is for the supply of Ondansetron HCL 8 mg tablets. The award falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary contract...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4VRDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office division. The award is a Delivery Order against Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's medical treatment programs and facilities worldwide. The specific award is for the supply of Ondansetron HCL 8 mg Tablets, with a ceiling value of $2,207.64 and a firm fixed price. The award does not have a set-aside designation, indicating it was competed on a full and open basis. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/16/24 |